Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021; 23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
In the 1910s, the American Medical Association fought quackery promoted in pamphlets for drugs and treatments for everything from teething to epilepsy.
AMA J Ethics. 2018; 20(11):E1082-1093. doi:
10.1001/amajethics.2018.1082.
A guardian’s request to sterilize a woman with intellectual disabilities is not ethically justifiable unless the woman assents and it is to her benefit.
AMA J Ethics. 2016; 18(4):365-372. doi:
10.1001/journalofethics.2016.18.4.ecas2-1604.
Feminism plays critical roles in innovating health care policies and practices. Feminist insights into clinicians as gatekeepers to gender-transition interventions can help resist tendencies to pathologize transgender.
AMA J Ethics. 2016; 18(11):1132-1138. doi:
10.1001/journalofethics.2016.18.11.msoc1-1611.
One transgender patient draws upon his transition experiences to suggest strategies for health care professionals looking to be more responsive to transgender patients’ needs.
AMA J Ethics. 2016; 18(11):1139-1146. doi:
10.1001/journalofethics.2016.18.11.mnar1-1611.
Katherine Gentry, MD, MA and Aaron Wightman, MD, MA
A patient’s refusal of tracheostomy during an anticipated difficult intubation prompts critical questions about how to best express respect for a pediatric patient’s autonomy and whether and when deviation from standard of care is clinically and ethically appropriate.
AMA J Ethics. 2018; 20(8):E683-689. doi:
10.1001/amajethics.2018.683.